Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/1998
08/12/1998CN1190351A Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with estrogen
08/12/1998CN1190349A Viral agent associated with mystery swine disease
08/12/1998CN1190333A Fat subsitutes containing water soluble beta-caroten
08/11/1998US5792901 Detecting prions in a sample and prion preparation and transgenic animal used for same
08/11/1998US5792838 Method for stabilizing immunoglobulin compositions
08/11/1998US5792834 Polyethylene-protein conjugates
08/11/1998US5792795 Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
08/11/1998US5792786 Sustained and prolonged wound healing agents
08/11/1998US5792753 Topical anticarcinogenic agent
08/11/1998US5792751 Tranformation of cells associated with fluid spaces
08/11/1998US5792645 Protein-polycation nucleic acid complexes and methods of use
08/11/1998US5792507 High surface smoothness and low abrasiveness
08/11/1998US5792478 Tissue injectable composition and method of use
08/11/1998US5792477 Emulsification of two phases; separation; washing; reducing level of residual solvent
08/11/1998US5792475 Lymphatic delivery composition
08/11/1998US5792458 Selectively killing tumor cells
08/11/1998US5792445 Polymers and copolymers of acrylic acid MRI of the digestive tract of patients
08/11/1998CA2217321A1 Polymers incorporating peptides
08/11/1998CA2085462C Antifungal ointment
08/11/1998CA2064160C Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
08/06/1998WO1998033914A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response
08/06/1998WO1998033808A2 A reversible stoichiometric process for conjugating biomolecules
08/06/1998WO1998033528A2 Induction of b cell tolerance
08/06/1998WO1998033521A1 Pneumococcal polysaccharide conjugate and pneumococcal polysaccharide cholera toxin b subunit conjugate vaccines
08/06/1998WO1998033519A1 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same
08/06/1998WO1998033514A1 Freeze-dried composition of bone morphogenetic protein human mp52
08/06/1998WO1998033512A1 Oil-free pharmaceutical compositions containing cyclosporin a
08/06/1998WO1998033508A1 Calcareous material
08/06/1998WO1998033486A1 Microparticles and their use in cancer treatment
08/06/1998WO1998033485A1 Method for removing high boiling solvents from drug formulations by vacuum drying
08/06/1998WO1998033483A1 Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
08/06/1998WO1998033482A1 Pain reducing parenteral liposome formulation
08/06/1998WO1998033481A1 Lipid complexes and liposomes of highly insoluble platinum complexes
08/06/1998WO1998033475A1 Active synergetic complex and cosmetic and/or pharmaceutical product containing this complex
08/06/1998WO1998033474A1 Use of oil from emu or rhea birds as trans-membrane carriers for delivery of drugs, peptides and vaccines
08/06/1998WO1998033470A2 Substituted perylenequinones for use in photodynamic therapy
08/06/1998WO1998024504A3 Device for local administration of solid and semisolid pharmaceutical formulations, sustained-release pharmaceutical formulations for parenteral administration and method of preparation
08/06/1998WO1998024436A3 Gel formulations for topical drug delivery
08/06/1998WO1998018451A3 Substituted amylose as a matrix for sustained drug release
08/06/1998WO1998017317A3 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates
08/06/1998WO1998010794A3 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
08/06/1998WO1998010767A3 Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
08/06/1998WO1998002148A3 Pharmaceutical composition
08/06/1998DE19724867C1 Use of emulsifier mixtures in pharmaceutical, cosmetic and shampoo compositions
08/06/1998CA2851502A1 Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
08/06/1998CA2692302A1 Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
08/06/1998CA2284463A1 A reversible stoichiometric process for conjugating biomolecules
08/06/1998CA2279594A1 Calcareous material
08/06/1998CA2279547A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response
08/06/1998CA2279544A1 Induction of b cell tolerance
08/06/1998CA2279259A1 Pain reducing parenteral liposome formulation
08/06/1998CA2278675A1 Hard gelatine capsules containing pharmaceutical compositions substantially free of any oil
08/06/1998CA2277362A1 Substituted perylenequinones for use in photodynamic therapy
08/05/1998EP0856316A1 Method for solubilizing pyridonecarboxylic acid, solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
08/05/1998EP0856313A1 Controlled absorption diltiazem formulations
08/05/1998EP0856312A1 Use of trospium chloride for the manufacture of a medicament for the treatment of diseases of the bladder
08/05/1998EP0856310A2 Method for stabilizing acriylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized acrylcarboxylic acid
08/05/1998EP0856054A1 Monoclonal antibody br110 and uses thereof
08/05/1998EP0856026A1 Discrete-length polyethylene glycols
08/05/1998EP0855919A1 Hormone immunomodulated induction of mucosal immune responses
08/05/1998EP0855917A1 Stable pharmaceutical forms of administration containing parathormone
08/05/1998EP0855914A1 Stable formulations of mhc-peptide complexes
08/05/1998EP0855913A1 Iron dextran formulations
08/05/1998EP0855910A1 Conjugates useful in the treatment of benign prostatic hyperplasia
08/05/1998EP0855907A1 Composition for transdermal delivery
08/05/1998EP0700294B1 Intramuscular and subcutaneous injection solution for animals
08/05/1998EP0675711B1 Atovaquone pharmaceutical compositions
08/05/1998EP0674510B1 Injectable composition comprising paclitaxel
08/05/1998EP0674505B1 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails
08/05/1998CN1189773A Sterile ophthalmological gel prepn. applicable in drops and processfor producing it
08/05/1998CN1189379A Virus inactivation method of HDL preparation
08/04/1998US5789655 Dna sequences
08/04/1998US5789555 Complexing
08/04/1998US5789554 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
08/04/1998US5789465 Collagen matrix
08/04/1998US5789445 Method for topical treatment of scar tissue and related tissue reaction to trauma
08/04/1998US5789399 Treatment of pruritus with vitamin D and analogs thereof
08/04/1998US5789387 Methods and compositions for treating fungal infections in mammals
08/04/1998US5789376 Transfusions with stabilized hemoglobin covalently bound to a nitroxide or polymers thereof
08/04/1998US5789244 Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems
08/04/1998US5789230 Endosomolytically active particles
08/04/1998US5789219 Phosphatase activated crosslinking conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents
08/04/1998US5789208 Polyclonal antibody libraries
08/04/1998US5789021 Coated layer of phosphor particles in a binder
08/04/1998US5788989 Dendrimer and an active substance occluded in the dendrimer, a process for the preparation thereof and a process for releasing the active substance
08/04/1998US5788987 Time-specific controlled release dosage formulation
08/04/1998US5788985 Comprising n-glycidyl ganglioside coupled to carier protein, adjuvant
08/04/1998US5788972 Dihydroxyacetone and lipase enzyme
08/04/1998CA2228536A1 Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
08/04/1998CA2228535A1 Method for solubilizing pyridonecarboxylic acid, solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
08/04/1998CA2102210C Combined calcium and vitamin d supplements
08/04/1998CA2025997C Non-toxic polyester compositions made with organotin esterification catalysts
08/04/1998CA1339980C Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same
07/1998
07/30/1998WO1998032873A1 New method for isolating polysaccharides
07/30/1998WO1998032718A1 New fatty acid derivatives
07/30/1998WO1998032467A2 Method and conjugate for treating h. pylori infection
07/30/1998WO1998032466A1 Pegylation process
07/30/1998WO1998032465A1 Composition for the transdermal administration of steroid drugs
07/30/1998WO1998032446A1 Urease-responsive delivery systems for diagnostic and therapeutic applications
07/30/1998WO1998032435A1 Liquid eye drop composition
1 ... 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 ... 1712